產品目錄

規格	5mg 25mg
CAS	1474034-05-3
別名	N/A
化學名	N/A
分子式	C33H44F2N2O3
分子量	554.71
溶解度	≥ 55.5mg/mL in DMSO, ≥ 25.05mg/mL in EtOH
儲存條件	Store at -20°C
General tips	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition	Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request

產品描述：

RTA-408 is an antioxidant inflammation modulator (AIM), which activates Nrf2 and suppresses nitric oxide (NO). RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling.

To evaluate the anti-inflammatory activity of RTA-408, RAW 264.7 mouse macrophage cells are treated with RTA-408 for two hours and then IFNγ is added to stimulate NO production and release into the media. RTA-408 dose-dependently reduces NO concentrations in the media with an IC50 value of 4.4±1.8 nM. The potency of RTA-408 in this assay is similar to that of Bardoxolone methyl, which has an IC50 value of 1.9±0.8 nM. Nrf2 activation is required for AIM-mediated NO suppression. A decrease in nitric oxide synthase 2 (Nos2) protein levels is observed in bardoxolone methyl-treated RAW 264.7 cells, which is attenuated when Nrf2 mRNA levels are reduced by siRNA. To evaluate the anticancer activity of RTA-408, a panel of eight human cell lines derived from tumors of different origin are treated with RTA-408 and measured cell growth 72 hours later using the sulforhodamine B (SRB) assay. RTA-408 inhibits the growth of all tumor lines with an average GI50 value of 260±74 nM. To determine whether RTA-408 induces apoptosis, the panel of tumor cells are treated with RTA-408 and the caspase substrate, DEVD-AFC, for 24 hours. RTA-408 dose-dependently increases DEVD-AFC cleavage, indicating that RTA-408 treatment triggers caspase activation in cancer cells. Caspase-3 and caspase-9 cleavage is also observed by western blot at the same concentrations of RTA-408 that increases DEVD-AFC cleavage[1].

To determine whether RTA-408 is an effective mitigator of hematopoietic acute radiation syndrome after bone marrow-lethal doses of total-body irradiation (TBI), mice are administered 3 daily injections of 17.5 mg/kg RTA-408 beginning 24 h after TBI. Teatment with RTA-408 results in the 35 day survival of 100% of 7 Gy (LD40/35) TBI mice (P<0.05) and 60% of 7.5 Gy (LD100/13) TBI mice (P<0.0001)[2].

特別提醒：

1. 本產品僅供科研使用。請勿用于醫藥、臨床診斷或治療，食品及化妝品等用途。請勿存放于普通住宅區。

2. 為了您的安全和健康，請穿好實驗服并佩戴一次性手套和口罩操作。

原創作者：上海莼試生物技術有限公司

在線咨詢

留言注意事項：

1.遵守中華人民共和國有關法律、法規，尊重網上道德，承擔一切因您的行為而直接或間接引起的法律責任。

2.請您真實的反映產品的情況,不要捏造、誣蔑、造謠。如對產品有任何疑問,也可以留言咨詢。

3.未經本站同意，任何人不得利用本留言簿發布個人或團體的具有廣告性質的信息或類似言論。

您感興趣的產品*
您的單位*
聯系人*
聯系電話*
詳細地址*
常用郵箱*
請輸入您對我們的意見或建議*
驗證碼*

同類產品

Sulfasalazine SD 1029 Vanoxonin Neriifolin Termitomycamide B nor-NOHA (acetate) Naphthazarin Tetrahydroxyquinone monohydrate Taurochenodeoxycholic Acid (sodium salt) apimod tetrahydrochloride

訂購流程

訂貨流程

產品訂購說明:

1、報價含普票、運費。

2、常用試劑備貨充足，除對溫度要求極其嚴格的產品當天可發貨。

3、進口原裝產品要3-6周的貨期，詳細情況請咨詢客服。

4、訂貨時間為工作日每周一至周五16:00之前。

5、如需代為檢測，標本對環境溫度高，可聯系客服安排專人取樣（限省內客戶）。

6、代測免收代測費，一周出結果。

7、產品因運輸途中包裝破損請拒絕簽收，做退回。我們將在24小時之內為您補發損壞產品。

8、如因單位財務制度原因，可申請先發貨，報賬后付款（此條款僅限醫院、學校信譽良好客戶）。

付款方式

普票匯款信息

賬戶名：上海生物

開戶行：中國銀行山東省分行營業部

賬號：2169 2341 6278

為方便廣大客戶辦理貨款我公司提供多個銀行的賬戶，學校、醫院客戶購買產品如因單位財務制度原因可先發貨待報賬后匯款，請及時告知銷售人員已做具體操作。

世俱杯2025赛程_中国足彩网首页官网_埃弗顿vs托特纳姆热刺_中国女排现状 - 奥运女足历届冠军一览表

Omaveloxolone (RTA-408)

產品目錄

聯系我們

技術服務

商品詳情購物流程代測服務付款方式常見問題

在線咨詢

同類產品

訂貨流程

付款方式